Stock comparison
Abbott Laboratories
ABT$176.09BHealthcare Market cap, Sector
Jeena Sikho Lifecare Limited
JSLL.BO$70.32BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
ABT 07 JSLL.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
ABT0wins
7winsJSLL.BO
49D
B84
66C
A87
38F
A92
16F
C66
37F
B75
45D
A91
43F
A95
Side-by-side metrics
| Metric | ABT | JSLL.BO |
|---|---|---|
| Market cap | Winner: $176.09B | $70.32B |
| P/E (TTM) | Winner: 26.9x | 33.2x |
| EV/EBIT | Winner: 20.2x | 24.1x |
| ROIC (TTM) | 11.0% | 39.15% Winner |
| Gross margin | 56.42% | 88.58% Winner |
| Net margin | 14.72% | 27.68% Winner |
| Revenue CAGR 5y | 0.51% | 57.81% Winner |
| EPS CAGR 5y | -1.73% | 86.67% Winner |
| Debt / Equity | Winner: 0.3x | 0.3x |
| Dividend yield | 2.83% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ABT leads on
- Market cap$176.09Bvs $70.32B+60%
- P/E (TTM)26.9xvs 33.2x+19%
- EV/EBIT20.2xvs 24.1x+16%
JSLL.BO leads on
- EPS CAGR 5y86.67%vs -1.73%+102%
- Revenue CAGR 5y57.81%vs 0.51%+99%
- ROIC (TTM)39.15%vs 11.0%+72%
- Net margin27.68%vs 14.72%+47%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.